Table 6.
Analysis on effect of drug intervention against fibrogenesis induced by bile duct-ligation in rats (n = 7,)
|
Group |
Sample (n) |
Fibrosis phase |
Fibrotic area within 1.5 mm2(mm2) |
|||
|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | |||
| Normal |
7 |
7 |
0 |
0 |
0 |
0 |
| Shamed |
7 |
7 |
0 |
0 |
0 |
0 |
| Model |
7 |
0 |
2 |
1 |
4 |
0.88 ± 0.46△△ |
| Silymarin |
7 |
0 |
3 |
2 |
2 |
0.62 ± 0.21* |
| Berberine |
7 |
0 |
4 |
2 |
1 |
0.38 ± 0.25** |
| CRAE |
7 |
0 |
4 |
2 |
1 |
0.55 ± 0.21* |
| Bear Bile |
7 |
0 |
5 |
1 |
1 |
0.32 ± 0.19** |
| TUDCA | 7 | 0 | 3 | 1 | 3 | 0.61 ± 0.32 |
△p < 0.05 when compared with normal group; △△p < 0.01 when compared with normal group; *p < 0.05 when compared with model group; **p < 0.01 when compared with model group.